DK1165560T3 - 2-Hydroxymethylcyclopropylidenmethylpuriner som antivirale midler - Google Patents
2-Hydroxymethylcyclopropylidenmethylpuriner som antivirale midlerInfo
- Publication number
- DK1165560T3 DK1165560T3 DK00913872T DK00913872T DK1165560T3 DK 1165560 T3 DK1165560 T3 DK 1165560T3 DK 00913872 T DK00913872 T DK 00913872T DK 00913872 T DK00913872 T DK 00913872T DK 1165560 T3 DK1165560 T3 DK 1165560T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- amino
- compounds
- purines
- hydroxypurine
- Prior art date
Links
- JDQJREHJQXEZDU-UHFFFAOYSA-N [2-(7h-purin-2-ylmethylidene)cyclopropyl]methanol Chemical class OCC1CC1=CC1=NC=C(NC=N2)C2=N1 JDQJREHJQXEZDU-UHFFFAOYSA-N 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940121357 antivirals Drugs 0.000 title 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 abstract 4
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 abstract 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 150000003212 purines Chemical class 0.000 abstract 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract 2
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical class C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 abstract 1
- GIIGHSIIKVOWKZ-UHFFFAOYSA-N 2h-triazolo[4,5-d]pyrimidine Chemical class N1=CN=CC2=NNN=C21 GIIGHSIIKVOWKZ-UHFFFAOYSA-N 0.000 abstract 1
- OCAODLAHPGXQIE-UHFFFAOYSA-N 6-azido-7h-purin-2-amine Chemical compound NC1=NC(N=[N+]=[N-])=C2NC=NC2=N1 OCAODLAHPGXQIE-UHFFFAOYSA-N 0.000 abstract 1
- IYWUSKBMXQERLH-UHFFFAOYSA-N 6-n-cyclopropyl-7h-purine-2,6-diamine Chemical compound C=12N=CNC2=NC(N)=NC=1NC1CC1 IYWUSKBMXQERLH-UHFFFAOYSA-N 0.000 abstract 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 abstract 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 abstract 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 abstract 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 229940104302 cytosine Drugs 0.000 abstract 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 229940113082 thymine Drugs 0.000 abstract 1
- 229940035893 uracil Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/267,839 US6352991B1 (en) | 1997-01-08 | 1999-03-12 | 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| PCT/US2000/006250 WO2000053603A1 (en) | 1999-03-12 | 2000-03-10 | 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1165560T3 true DK1165560T3 (da) | 2005-03-14 |
Family
ID=23020343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00913872T DK1165560T3 (da) | 1999-03-12 | 2000-03-10 | 2-Hydroxymethylcyclopropylidenmethylpuriner som antivirale midler |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US6352991B1 (es) |
| EP (1) | EP1165560B1 (es) |
| JP (1) | JP2002539125A (es) |
| AT (1) | ATE282617T1 (es) |
| CA (1) | CA2366624C (es) |
| DE (1) | DE60015945T2 (es) |
| DK (1) | DK1165560T3 (es) |
| ES (1) | ES2234579T3 (es) |
| PT (1) | PT1165560E (es) |
| WO (1) | WO2000053603A1 (es) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6352991B1 (en) * | 1997-01-08 | 2002-03-05 | Wayne State University | 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
| PT1490368E (pt) * | 2002-03-15 | 2011-10-24 | Univ Michigan | 2,2-bis(hidroximetil)ciclopropilidenometil-purinas e ¿pirimidinas como agentes antivirais |
| EP1490015B1 (en) * | 2002-03-15 | 2009-09-23 | Wayne State University | Novel 2-amino-9-((2-hydroxymethyl) cyclopropylidenemethyl) purines as antiviral agents |
| UA79293C2 (en) * | 2002-07-03 | 2007-06-11 | Univ Wayne State | 4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents |
| US20070167353A1 (en) * | 2003-10-24 | 2007-07-19 | John Hilfinger | Prodrug composition |
| WO2006101062A1 (ja) * | 2005-03-22 | 2006-09-28 | Daiichi Sankyo Company, Limited | １－アルキルピロリジン構造を有するカルバペネム誘導体の製造方法 |
| WO2007023768A1 (ja) * | 2005-08-24 | 2007-03-01 | Eisai R & D Management Co., Ltd. | 新規ピリジン誘導体およびピリミジン誘導体（３） |
| US7473683B2 (en) | 2005-09-14 | 2009-01-06 | The Board Of Trustees Of The Leland Stanford Junior University | Nonpolar thymidine analogs |
| ATE535520T1 (de) * | 2006-08-23 | 2011-12-15 | Eisai R&D Man Co Ltd | Salz eines phenoxypyridinderivats oder kristall davon und verfahren zu dessen herstellung |
| JP2009132660A (ja) * | 2007-11-30 | 2009-06-18 | Eisai R & D Management Co Ltd | 食道癌治療用組成物 |
| JP2009203226A (ja) * | 2008-01-31 | 2009-09-10 | Eisai R & D Management Co Ltd | ピリジン誘導体およびピリミジン誘導体を含有するレセプターチロシンキナーゼ阻害剤 |
| WO2009104520A1 (ja) * | 2008-02-18 | 2009-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | フェノキシピリジン誘導体の製造方法（２） |
| WO2011022712A1 (en) * | 2009-08-21 | 2011-02-24 | Epiphany Biosciences, Inc. | Method of treating infectious mononucleosis with acylic nucleoside derivatives |
| CN104892709B (zh) * | 2015-06-04 | 2018-01-19 | 新乡学院 | 一种合成奈拉滨的方法 |
| CN112105624B (zh) * | 2018-03-09 | 2023-09-22 | 美迪维尔公司 | 使用(2,2-双羟甲基)亚甲基环丙烷核苷酸治疗癌症 |
| CN108314655B (zh) * | 2018-03-29 | 2021-01-15 | 河南师范大学 | 一种铑催化不对称环丙化合成三元碳环嘧啶核苷类似物的方法 |
| CN113185514A (zh) * | 2021-03-11 | 2021-07-30 | 杨锦飞 | 一种抗乙型肝炎病毒药物的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62116582A (ja) * | 1985-09-24 | 1987-05-28 | ヘキスト・アクチエンゲゼルシヤフト | ６−および９−位が置換された２−アミノプリン |
| US4935427A (en) | 1987-12-31 | 1990-06-19 | The United States Of America As Represented By The Department Of Health And Human Services | Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents |
| WO1998030563A1 (en) * | 1997-01-08 | 1998-07-16 | The Regents Of The University Of Michigan | 2-hydroxymethylcyclopropyli- denemethylpurines and -pyrimidines as antiviral agents |
| US6352991B1 (en) * | 1997-01-08 | 2002-03-05 | Wayne State University | 2-hydroxymethylcyclopropylidenemethylpurines and -pyrimidines as antiviral agents |
-
1999
- 1999-03-12 US US09/267,839 patent/US6352991B1/en not_active Expired - Fee Related
-
2000
- 2000-03-10 DK DK00913872T patent/DK1165560T3/da active
- 2000-03-10 DE DE60015945T patent/DE60015945T2/de not_active Expired - Lifetime
- 2000-03-10 CA CA002366624A patent/CA2366624C/en not_active Expired - Fee Related
- 2000-03-10 WO PCT/US2000/006250 patent/WO2000053603A1/en active IP Right Grant
- 2000-03-10 ES ES00913872T patent/ES2234579T3/es not_active Expired - Lifetime
- 2000-03-10 JP JP2000604040A patent/JP2002539125A/ja active Pending
- 2000-03-10 PT PT00913872T patent/PT1165560E/pt unknown
- 2000-03-10 EP EP00913872A patent/EP1165560B1/en not_active Expired - Lifetime
- 2000-03-10 AT AT00913872T patent/ATE282617T1/de active
-
2002
- 2002-01-14 US US10/047,202 patent/US6790841B2/en not_active Expired - Fee Related
-
2004
- 2004-08-06 US US10/913,219 patent/US6958345B2/en not_active Expired - Fee Related
-
2005
- 2005-10-25 US US11/257,776 patent/US20060122203A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2366624A1 (en) | 2000-09-14 |
| EP1165560A1 (en) | 2002-01-02 |
| US6790841B2 (en) | 2004-09-14 |
| EP1165560A4 (en) | 2002-04-17 |
| DE60015945D1 (en) | 2004-12-23 |
| EP1165560B1 (en) | 2004-11-17 |
| US20050009842A1 (en) | 2005-01-13 |
| DE60015945T2 (de) | 2005-11-03 |
| ATE282617T1 (de) | 2004-12-15 |
| PT1165560E (pt) | 2005-04-29 |
| US6958345B2 (en) | 2005-10-25 |
| ES2234579T3 (es) | 2005-07-01 |
| US6352991B1 (en) | 2002-03-05 |
| WO2000053603A1 (en) | 2000-09-14 |
| CA2366624C (en) | 2007-06-12 |
| WO2000053603A9 (en) | 2002-05-10 |
| US20060122203A1 (en) | 2006-06-08 |
| US20020193353A1 (en) | 2002-12-19 |
| JP2002539125A (ja) | 2002-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1165560T3 (da) | 2-Hydroxymethylcyclopropylidenmethylpuriner som antivirale midler | |
| CA2239968A1 (en) | Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| MXPA04003795A (es) | Compuestos de pirimidina y composiciones farmaceuticas que contienen los compuestos. | |
| DK373487A (da) | N-fosfonylmetoxyalkylpyrimidiner og -puriner samt farmaceutisk praeparat indeholdende saadanne forbindelser | |
| ITMI931396A1 (it) | Analoghi eterociclici di 1, 2, 4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina | |
| WO2002069903A3 (en) | Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases | |
| BRPI0107403B8 (pt) | Compostos de n-(5,7-dimetóxi[1,2,4]triazolo[1,5-alfa]pirimidin-2-il) arilsulfonamida e o uso dos mesmos como herbicidas. | |
| WO2003022805A3 (en) | Heterocycle substituted purines as antiproliferative agents | |
| ATE207077T1 (de) | Nucleosid-derivate mit photolabilen schutzgruppen | |
| WO2003068776A1 (fr) | Derives de (1, 2, 4) triazolo (1,5-c) pyrimidine | |
| WO2003104440A3 (en) | PURINES OR PYRIMIDINES 2,2-BIS- (HYDROXYMETHYL) CYCLOPROPYLIDENEMETHYLE USED AS ANTIVIRAL AGENTS | |
| DK1068209T3 (da) | Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter | |
| ATE247656T1 (de) | Pyrazolo(1,5-a)triazine als crf antagonisten | |
| JP2001517659A5 (es) | ||
| ATE238334T1 (de) | Nucleosid-derivate mit photolabilen schutzgruppen | |
| NO983656L (no) | Heterocyklyl-ergolinderivater som 5-HT1A reseptorligander | |
| WO1997003082A3 (en) | Pyrimidine nucleoside derivatives | |
| MX9701111A (es) | Oligomeros especificos de union de secuencia para acidos nucleicos y su uso en estrategias antisentido. | |
| WO2003028712A3 (en) | Purinergic and pyrimidinergic receptor agonists for the treatment of activated cd4+ t lymphocyte-mediated immune diseases | |
| KR910004621A (ko) | 신규 화합물 | |
| KR870010053A (ko) | 제초제 | |
| FI956246A (fi) | Hiili-asykliset nukleosidijohdannaiset antiviraalisina ja antineoplastisina aineina | |
| KR890003754A (ko) | 제초제 |